This article is more than 5 years old. Information may no longer be current.

Bioventus launches SUPARTZ FX with expanded label for repeat cycles in knee OA

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Bioventus recently announced the launch of SUPARTZ FX, which now has an expanded safety label to permit for repeat injection cycles to help patients with knee osteoarthritis manage pain and remain active.

According to a company press release, SUPARTZ FX aids in the restoration of the body’s natural hyaluronic acid (HA) production. The release notes that HA products, like SUPARTZ FX, possibly aid in the delay of total knee arthroplasty. SUPARTZ FX is only available for sale in the United States.

“SUPARTZ FX builds upon the success of SUPARTZ and ARTZ to alleviate [osteoarthritis] OA knee pain and since the introduction of SUPARTZ, more than 300 million injections of this HA have been prescribed globally,” Tony Bihl, chief executive officer of Bioventus, stated in the release. “The clinically proven expanded label allows Bioventus to continue to provide physicians and patients with an OA treatment that is safe for repeat courses of treatment.”

Reference: www.bioventusglobal.com/news/press-releases/bioventus-launches-supartx-fx%E2%84%A2-now-expanded-safety-label-repeat-injection-cycles#sthash.NDxjtpcw.dpuf.